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Underestimating the 
true impact of obesity
Authors’ reply
We thank Jacob Bradshaw and 
colleagues for their careful reading of 
our paper1 and the useful points that 
they raise. They suggest that we might 
have underestimated the true impact of 
obesity on non-communicable disease 
because outcome ascertainment for 
selected disorders might have been 
imprecise, and we did not consider all 
obesity-related conditions when we 
formulated our endpoint.
We utilised the six most common 
non-communicable diseases in 
developed countries which are also 
WHO’s priorities for prevention.2 We 
agree that this list is not exhaustive, 
and the full impact of obesity might 
have been underestimated as a 
consequence.
However, there are several reasons to 
anticipate that an overestimation could 
have occurred in our computations. 
First, ascertainment of disease cases 
was, as Bradshaw and colleagues 
highlight, made by linkage to records 
from hospital and death registries. 
This is of course imperfect, missing less 
severe forms of chronic disease. This 
could be a source of overestimation 
of obesity-related burden because 
disease severity is concurrent to body-
mass index, which leads to a more 
likely detection of those diseases that 
accompany severe obesity.
Second, we did an observational 
study which is inevitably subject to 
the perennial problem of residual 
confounding.  Because confounding 
typically inflates associations, it is 
likely that this also contributed to an 
overestimation of our obesity-disease 
estimates. Of the obesity-related 
conditions featured in our analyses, 
a causal influence on type 2 diabetes, 
coronary heart disease, and selected 
cancers only is supported by evidence 
from randomised controlled trials and 
Mendelian Randomisation analyses—
theoretically less subject to concerns 
of confounding—in combination 
with findings from mechanistically-
orientated studies.3-6  However, the 
positive associations of body-mass 
index with asthma and cancers of 
all sites, which also comprised our 
outcome, could be at least partially 
attributable to confounding, again 
tending towards an overestimation of 
burden in the present analyses.
These points illustrate the multiple 
factors that could cause bias in effect 
estimates. Their net effect needs 
to be considered before one can be 
confident that our results were indeed 
an underestimate of the burden of 
disease due to obesity.
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